Trademark: PLEXXIKON SCAFFOLD-BASED DRUG DISCOVERY
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
PLEXXIKON SCAFFOLD-BASED DRUG DISCOVERY
Click here to search for trademarks similar to PLEXXIKON SCAFFOLD-BASED DRUG DISCOVERY
Proof of use for PLEXXIKON SCAFFOLD-BASED DRUG DISCOVERY
We do not have any records of a proof of use for PLEXXIKON SCAFFOLD-BASED DRUG DISCOVERY at this moment.
Click here to add a proof of use for PLEXXIKON SCAFFOLD-BASED DRUG DISCOVERY
Possible trademark infringements of PLEXXIKON SCAFFOLD-BASED DRUG DISCOVERY
Basic Information about PLEXXIKON SCAFFOLD-BASED DRUG DISCOVERY
- Serial Number
- 87503353
- Filing Date
- 23 Jun 2017
- Mark Drawing Code
- 3
Classifications
Declare the trademark use of PLEXXIKON SCAFFOLD-BASED DRUG DISCOVERY on the blockchain with WikiTrademarks.io.
- First use of PLEXXIKON SCAFFOLD-BASED DRUG DISCOVERY anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 006; 018; 044; 046; 051; 052
Who owns PLEXXIKON SCAFFOLD-BASED DRUG DISCOVERY?
1. Plexxikon Inc. Berkeley CA
2. Plexxikon Inc. Berkeley CA
Correspondent
- Harold Milstein
- SHEPPARD MULLIN RICHTER & HAMPTON LLP
- 379 LYTTON AVENUE
- PALO ALTO, CA 94301
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io